Tradestie Institutional Equity Comparison Engine

ANNX vs FDMT โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

FDMT Overall Edge

FDMT Captures Institutional Edge (2โ€“1 Pillars ยท 4โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to 4D Molecular Therapeutics, Inc. Common Stock (FDMT) driven by superior Momentum & Technical, Options & Structure while ANNX counters with relative strength in Growth & Margin. Fundamentally, ANNX trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus FDMT at N/M Forward P/E and -222.7% operating margin (+4505.6% YoY). In options structure, ANNX sits in BREAKDOWN (40th %ile IV; Dealer Gamma Walls on Pro) against FDMT sits in BREAKDOWN (10th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
ANNX N/M vs FDMT N/M Fwd P/E
Growth & Margin Winner ANNX
Op Margin 0.0% vs -222.7% ยท YoY +0.0% vs +4505.6%
Momentum & Technical Winner FDMT
1Y +33.8% vs +13.3% ยท 52W Pos 22% vs 47%
Options & Structure Winner FDMT
BREAKDOWN (40th %ile IV) vs BREAKDOWN (10th %ile IV)
ANNX NASDAQ
Annexon, Inc. Common Stock
Pharmaceutical Preparations
$3.58
-8.55% 1D
Market Cap $757.3M
1M Return +5.13%
1Y Return +33.77%
Forward P/E N/M
Unified AI Score
44.6 / 100 HOLD
Tech 42.0 Fund 54.0 Flow 68.0 Mom 60.0
FDMT NASDAQ
4D Molecular Therapeutics, Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$11.65
-4.74% 1D
Market Cap $669.3M
1M Return -4.04%
1Y Return +13.33%
Forward P/E N/M
Unified AI Score
51.3 / 100 HOLD
Tech 51.0 Fund 47.0 Flow 66.0 Mom 54.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ANNX +33.77% FDMT +13.33% Spread: +20.44 pp (ANNX Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
ANNX TTM Op. Margin: 0.0% FDMT TTM Op. Margin: -222.7%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ANNX vs FDMT. Trailing 12-month operating profitability (ANNX 0.0% vs FDMT -222.7%) and valuation multiples (ANNX N/M vs FDMT N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ANNX (4) vs FDMT (4)
Institutional Metric ANNX FDMT Criterion Row Winner
Market Capitalization Scale $757.3M $669.3M Larger Scale ANNX
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +0.0% +4505.6% Higher Growth FDMT
Operating Margin (TTM) Profitability 0.0% -222.7% Higher Margin ANNX
Net Profit Margin Profitability 0.0% -208.6% Higher Margin ANNX
Return on Equity (ROE) Capital Efficiency -130.8% -56.7% Higher ROE FDMT
52-Week Range Position Momentum 22% ($3โ€“$7) 47% ($7โ€“$17) Stronger Trend FDMT
Beta / 30D Volatility Risk Regime 1.68ฮฒ ยท 62% Vol 1.89ฮฒ ยท 90% Vol Lower Realized Risk ANNX
Unified Institutional Score Composite Signal 44.6 / 100 (HOLD) 51.3 / 100 (HOLD) Higher Composite FDMT

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ANNX vs FDMT Buy Guide
ANNX BREAKDOWN
87d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 40th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live ANNX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
FDMT BREAKDOWN
62d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 10th %ile
IV Regime Compressed (<25th %ile)
Live FDMT Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ANNX nor FDMT registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.